Merck shares rose after partner Kelun-Biotech reported positive late-stage trial results for a Keytruda combination treatment ...
MarketBeat on MSN
Karyopharm Therapeutics spotlights selinexor milestones, ASCO data and cancer trial readouts
Key Points Interested in Karyopharm Therapeutics Inc.? Here are five stocks we like better. Karyopharm highlighted upcoming ...
Akari said its experimental therapy AKTX-101 showed strong results when paired with an already-approved cancer drug in lab ...
CG Oncology (NASDAQ:CGON) executives used an RBC Capital Markets fireside chat to outline recent clinical data for cretostimogene, the company’s investigational therapy for non-muscle invasive bladder ...
A significant number of cancer patients—particularly those with more advanced cancers who are more likely to receive care at ...
As recognized leaders in cancer research, Huntsman Cancer Institute physicians and scientists are utilizing artificial intelligence (AI) to accelerate discoveries and improve patient care. When I was ...
Researchers project that 618,120 people will die from cancer in the US this year, which works out to about 1700 deaths per day. The American Cancer Society (ACS) has released cancer statistics for ...
Megan Sweet slices tumors. A normal day in the lab finds the Virginia Tech graduate student with hands deep inside a refrigerated metal box, pulling a mounted mouse-grown tumor incrementally closer to ...
Credit: Getty Images. Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. Breast cancer is the second most common cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results